Ignite Creation Date:
2025-12-25 @ 2:39 AM
Ignite Modification Date:
2025-12-26 @ 1:17 AM
Study NCT ID:
NCT01180634
Status:
COMPLETED
Last Update Posted:
2024-12-18
First Post:
2010-08-10
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
MP-376 (Aeroquin™, Levofloxacin for Inhalation) in Patients With Cystic Fibrosis
Sponsor:
Amgen
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2010-11-04
Start Date Type:
ACTUAL
Primary Completion Date:
2012-05-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2012-05-07
Completion Date Type:
ACTUAL
First Submit Date:
2010-08-10
First Submit QC Date:
None
Study First Post Date:
2010-08-12
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2024-03-18
Results First Submit QC Date:
None
Results First Post Date:
2024-04-30
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2018-01-19
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2024-12-02
Last Update Post Date:
2024-12-18
Last Update Post Date Type:
ACTUAL